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a  b  s  t  r  a  c  t
Recombinant  yeast  pyruvate  carboxylase  (PYC2)  expression  was  previously  shown  to be  an  effective
metabolic  engineering  strategy  for reducing  lactate  formation  in  a number  of  relevant  mammalian  cell
lines, but,  in  the  case  of  CHO  cells,  did not  consistently  lead  to  signiﬁcant  improvement  in  terms  of  cell
growth,  product  titer and energy  metabolism  efﬁciency.  In the present  study,  we  report  on the  establish-
ment  of a PYC2-expressing  CHO  cell  line  producing  a monoclonal  antibody  and  displaying  a signiﬁcantly
altered  lactate  metabolism  compared  to  its parental  line.  All  clones  exhibiting  strong  PYC2  expression
were  shown  to experience  a signiﬁcant  and  systematic  metabolic  shift  toward  lactate  consumption,  as
well as a prolonged  exponential  growth  phase  leading  to  an  increased  maximum  cell concentration  andetabolic engineering
ed-batch
onoclonal antibody
volumetric  product  titer.  Of salient  interest,  PYC2-expressing  CHO  cells  were  shown  to  maintain  a  highly
efﬁcient  metabolism  in fed-batch  cultures,  even  when  exposed  to  high  glucose  levels,  thereby  alleviating
the  need  of controlling  nutrient  at low  levels  and  the  potential  negative  impact  of such  strategy  on  prod-
uct  glycosylation.  In bioreactor  operated  in  fed-batch  mode,  the higher  maximum  cell density  achieved
with  the  PYC2  clone  led to  a net  gain  (20%)  in  ﬁnal  volumetric  productivity.
Crown  Copyright  ©  2015  Published  by Elsevier  B.V.  This  is an  open  access  article  under  the  CC. Introduction
Whether to support new therapeutic antibody development or
o respond to market needs, the ability to cost-efﬁciently gener-
te high yield and high quality of biotherapeutics is critical for
he biopharmaceutical industry, owing to the great pressure to
ower the cost and shorten the period between drug discovery
nd product manufacturing. The development and implementa-
ion of high-yield fed-batch strategies has contributed greatly at
ncreasing the productivity of mammalian cell cultures (Bibila and
obinson, 1995; Wlaschin and Hu, 2006; Wurm,  2004). In fed-
atch processes, the prolonged culture time is often associated
ith signiﬁcant lactate and ammonia accumulation in the culture
edium over time, which can have detrimental impacts on cell
rowth and product quality. Continuous cell lines, like CHO cells,
how a deregulated glucose metabolism associated with high lac-
∗ Corresponding author at: Life Sciences, NRC Human Health Therapeutics Port-
olio, Building Montreal-Royalmount, National Research Council Canada, Montréal,
uébec H4P 2R2, Canada. Fax: +1 514 496 7251.
E-mail addresses: cecile.toussaint@umontreal.ca (C. Toussaint),
.henry@polymtl.ca (O. Henry), yves.durocher@nrc-cnrc.gc.ca (Y. Durocher).
ttp://dx.doi.org/10.1016/j.jbiotec.2015.11.010
168-1656/Crown Copyright © 2015 Published by Elsevier B.V. This is an open acces
y-nc-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
tate production that can cause medium acidiﬁcation or undesired
osmolality changes due to alkali addition for culture pH control
(Cruz et al., 2000; Lao and Toth, 1997; Omasa et al., 1991; Ozturk
et al., 1992). Ammonia is well-known to alter the glycosylation pat-
terns of monoclonal antibodies and other glycoproteins (Andersen
and Goochee, 1995; Borys et al., 1994; Chen and Harcum, 2006;
Gawlitzek et al., 2000; Yang and Butler, 2002). Appropriate gly-
cosylation of monoclonal antibodies and recombinant proteins is
necessary to ensure their biological function and their use as ther-
apeutics. Thus, maintaining consistent and comparable product
quality in high cell density cultures remains a critical challenge.
Several waste reduction strategies have been proposed using
either metabolic or process engineering approaches. This includes
the use of nutrients replacement strategies, for example the
substitution of glucose with galactose (Altamirano et al., 2006,
2000, 2004) or pyruvate (Genzel et al., 2005) or substituting
glutamine with asparagine (Kurano et al., 1990) or glutamate
(Altamirano et al., 2000; Hassel and Butler, 1990). While effective
at reducing waste metabolite formation, these substitutions are
often associated with a concomitant reduction in cellular growth.
Reduced lactate and ammonia production during fed-batch can be
achieved by maintaining glucose and glutamine at very low levels
s article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Omasa et al., 1992; Zhou et al., 1995). Under low nutrient availabil-
ty, the cell metabolism is shifted toward a more efﬁcient metabolic
tate characterized by a lower molar ratio of lactate/glucose (Chee
urng Wong et al., 2005; Maranga and Goochee, 2006). However,
his requires the constant monitoring of nutrient levels and feed
ate adjustments since non-limiting concentrations must be main-
ained at all time during the culture. Even short period of glucose
tarvation were shown to alter the glycosylation of the product
Xie et al., 1997). Moreover, it has been demonstrated that low glu-
ose concentrations (<15 mM)  lead to reduced site occupancy and
ecreased galactosylation and sialylation of antibodies (Liu et al.,
014). A dynamic fed-batch strategy to maintain low glutamine
0.1–0.3 mM)  and glucose (0.35–0.70 mM)  concentrations was also
hown to decrease complex-type glycan formation and sialic acid
ontent (Chee Furng Wong et al., 2005). These results emphasize
he need to optimize both product titer and quality concurrently.
Different metabolic engineering approaches have also been
nvestigated to generate cell lines with improved metabolic char-
cteristics. The ampliﬁcation of the glutamine synthetase gene in
HO and myeloma cells allowed growth in glutamine-free medium,
hereby signiﬁcantly reducing ammonia formation (Paredes et al.,
999; Zhang et al., 2006). Partial disruption of the gene encoding
actate dehydrogenase A by the means of homologous recombi-
ation in hybridoma cells (Chen et al., 2001) or siRNA in CHO cells
Jeong et al., 2006; Kim and Lee, 2007a) was shown to greatly lower
he production of lactate, as well as glucose consumption. Studies
y Chen et al. (2001) and Kim and Lee (2007a) on the down regula-
ion of LDHA led to increased ﬁnal product concentrations, although
ell growth remained unaffected. In contrast, Jeong et al. (2006)
bserved an increased cell growth rate, but no signiﬁcant impact
n tPA production unless downregulation of LDH was combined
ith the overexpression of glycerol-3-phosphate dehydrogenase.
 recent study demonstrated that the simultaneous downregula-
ion of LDH and pyruvate dehydrogenase kinase can signiﬁcantly
educe lactate accumulation and increase the volumetric antibody
roduction, without impairing cell growth (Zhou et al., 2011). The
xpression of anti-apoptotic genes was also found to signiﬁcantly
lter the lactate metabolism of CHO cells, inducing a metabolic
hift toward lactate consumption and increasing the ﬁnal antibody
iter by 40% (Dorai et al., 2009). Another approach consisted in the
xpression of the cytosolic yeast pyruvate carboxylase 2 (PYC2)
ene in BHK (Irani et al., 1999) and HEK293 cells (Elias et al., 2003;
enry and Durocher, 2011; Vallée et al., 2013). In all cases, lactate
ormation was signiﬁcantly decreased and, depending on the cell
ype and prevailing culture conditions, translated into improve-
ent of either productivity or cell growth, but not both. In the case
f CHO cells, two strategies were explored. First, the insertion of
he human pyruvate carboxylase (hPC) gene in DG44 cells, which
ed to a slight decrease in lactate production (Kim and Lee, 2007b),
s this enzyme is expressed in the mitochondria and is therefore
ot competing directly with LDH for pyruvate conversion. Second,
ne study reported on the expression of PYC2 in CHO cells, which
llowed to decrease the speciﬁc lactate production (Fogolín et al.,
004). However, the molar ratio of lactate/glucose remained high
∼1.5) and relatively unchanged compared to the untransformed
ells (∼1.7), indicating that the reduction in lactate accumulation
as mostly due to a decrease in glucose uptake rate. Moreover,
hile prolonged cell viability was observed, this was at the expense
f the maximum cell density, which exhibited a 2-fold reduction
n batch culture. Recently, PYC2 overexpression in CHO cells was
hown to prolong culture longevity and reduce the lactate/glucose
atio by 25%, but at the expense of a 50% reduction in the cell spe-
iﬁc antibody production rate and an overall decrease in antibody
iter (Wilkens and Gerdtzen, 2015).
In the present work, we show the establishment of a PYC2-
xpressing CHO cell line with a greatly improved metabolichnology 217 (2016) 122–131 123
efﬁciency that translated into reduced lactate accumulation with-
out impairing the cells’ speciﬁc productivity. All the PYC2-
expressing clones that were generated exhibited a prolonged
exponential growth phase leading to increases in maximum cell
concentration and volumetric productivity. We  also demonstrate
that the PYC2-expressing cells can maintain their improved phe-
notype during fed-batch cultures employing concentrated nutrient
solutions. In fed-batch bioreactor cultures, this resulted in further
signiﬁcant increases in terms of maximum cell density and ﬁnal
product titer.
2. Materials and methods
2.1. Stable cell line development
The CHO-EG2 clone 1A7 stably expressing a chimeric human-
llama heavy chain monoclonal antibody (EG2) against epidermal
growth factor receptor (EGFR) (Bell et al., 2010) was established
from the CHO-DUXB11 cell line (Agrawal et al., 2012). The CHO-
EG2-PYC2 clone was obtained by transfection of the CHO-EG2 cell
line with the pTT18 vector encoding the yeast pyruvate carboxy-
lase 2 gene. After transfection, hygromicin B was  added to the cell
culture at a ﬁnal concentration of 900 g/mL. After two weeks of
selection, the pool of hygromycin-resistant cells was  cloned by
limiting dilution in 96-well plate. After 2 weeks, colonies were
expanded and screened for their PYC2 expression level by west-
ern blot. Since the PYC2 enzyme is naturally biotinylated, it allows
its detection using HRP-conjugated streptavidin (Sigma). Brieﬂy,
cells pellets were incubated on ice 20 min  in a lysis buffer contain-
ing 50 mM HEPES pH 7.4, 150 mM NaCl, 1% Thesit® (Roche), 0.5%
Na Deoxycholate, 1× complete-protease inhibitor cocktail (Roche).
Cell lysates were centrifuged for 20 min  at 12,000 × g at 4 ◦C.
Supernatants were incubated 5 min  at 90 ◦C in SDS sample buffer
containing 5 mM dithiothreitol. Samples were electrophoresed on
an SDS polyacrylamide gel electrophoresis (PAGE) and transferred
onto a nitrocellulose membrane (Schleicher & Schuell). Mem-
branes were probed with HRP-conjugated streptavidin (Sigma).
An anti-GAPDH rabbit polyclonal antibody (Sigma) was utilized
for detection of the GAPDH to control total protein load. As
a secondary antibody, an anti-rabbit polyclonal antibody HRP-
conjugated (sigma) was  employed. The blots were developed using
a chemiluminescence kit (Boehringer Mannheim, Germany) and
visualized with the Kodak imager system 440CF.
2.2. Fed-batch culture in shake ﬂasks for clone evaluation
Eleven PYC2-positive clones and 4 PYC2-negatives clones were
cultivated in 250 mL  shake-ﬂasks. After 4 days of cultivation, glu-
cose was added daily in order to maintain a concentration of 20 mM.
Lactate formation was measured daily for phenotypic screening to
conﬁrm that the change in lactate metabolism was the results of
PYC2 overexpression rather than clonal effect.
2.3. PYC2 cytosolic expression
Three clones were selected according to their stable expression
of PYC2. In order to conﬁrm cytosolic PYC2 expression, the cytosols
of these clones were isolated using mitochondria isolation kit for
cultured cells (Thermo Scientiﬁc- cat#89874). Their PYC2 expres-
sion level was assessed by western blot using HRP-conjugated
streptavidin (Sigma) as described before.2.4. Medium and culture conditions
PowerCHO2 chemically deﬁned medium (Lonza) supplemented
with 8 mM glutamine, 0.1% Kolliphor® (Sigma) and 2% (v/v) anti
1 Biotechnology 217 (2016) 122–131
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Fig. 1. Generation of a stable cell line expressing PYC2. (A) Example of western
blot analysis of CHO cells transfected with the PYC2 gene. PYC2 and PC expression
levels are detected using HRP-conjugated streptavidin. Lane 1: parental cell line
(untransfected), lanes: 2, 4, 7, 24: PYC2 positive clones. Lanes: 3, 5, 6–23, 25: PYC2
negative clones. (B) Western blot of the 11 PYC2 positive clones chosen for batch24 C. Toussaint et al. / Journal of 
lumping agent (Gibco) was used for stable cell line development
nd batch shake-ﬂasks experiments. Cultures were inoculated at
 cell concentration of 0.2 × 106 cells/mL and were grown at 37 ◦C
nd 5% CO2 under constant agitation (120 rpm).
.5. pH monitoring in 6-well plates
Cell cultures were inoculated at a cell concentration of 0.2 × 106
ells/mL and grown at 37 ◦C and 5% CO2 under constant agitation
120 rpm) in 6-well plates with integrated pH sensors (HydroDish®,
reSens-Precision Sensing GmbH, Germany).
.6. Fed-batch cultivation
For fed-batch cultivation in shake ﬂask or bioreactor, cells
ere seeded at a target cell concentration of 0.2 × 106 cells/mL in
alanCD (Irvine) chemically deﬁned medium supplemented with
 mM glutamine, 0.1% Kolliphor® and 2% (v/v) anti clumping agent
Gibco). Samples were taken daily to measure the cell density and
utrient/metabolite concentrations. Once the analyses completed,
ddition of CHO CD EfﬁcientFeedTM B (Gibco) supplemented with
0 mM of glutamine was performed on a daily basis. The daily feed-
ng volume is calculated according to the cell speciﬁc consumption
f glucose:
eedVolume =
(
R × IVCDpredicted
)
−
(
Ct × V − Ctarget × V
)
Cfeed
here R denotes the speciﬁc nutrient consumption rate. Ct and
target are the nutrient concentration and the desired nutrient con-
entration, respectively. V denotes the volume of the vessel and
feed represents the nutrient concentration in the feed.
.7. Bioreactor
Bioreactor experiments were performed in 2 L stirred bioreactor
Labfors 4 cell, Infors HT, Switzerland) operated at a 0.6 L starting
olume. Dissolved oxygen was maintained at 50% of air saturation
y surface aeration using a gas mixture of oxygen/nitrogen/air with
 gas ﬂow set at 100 mL/min. When necessary, pure oxygen was
parged at 2 mL/min with an on/off controller. The temperature was
aintained at 37 ◦C with a double-wall water-jacketed. The stirring
peed started at 80 rpm and was gradually increased during culture
o reduce cell clumping and optimize gas transfer, until a maximum
f 120 rpm. Culture pH was controlled at 7.0 by a surface gassing of
O2 or 1 M sodium hydroxide addition. Addition of feeding medium
as operated with a digital tubing pump delivering the desired feed
olume at a ﬂow rate of 280 L/min.
.8. Analytical methods
.8.1. Cell count and viability, glucose, lactate, ammonium,
lutamine quantiﬁcation
Cell number and viability were assessed by trypan blue exclu-
ion and counting on a hemocytometer. Samples were centrifuged
nd the supernatants were frozen at −80 ◦C for subsequent analysis.
he glucose, lactate and glutamine concentrations in supernatants
ere measured with YSI 2700 Select biochemistry analyzer (Yel-
ow Spring, USA). Ammonia concentration was measured by the
ITROS 350 (Orthoclinical Diagnostics, USA).
.8.2. Antibody quantiﬁcation
Antibody quantiﬁcation in supernatants was determined by
igh performance liquid chromatography (WATERS Corporation,
ilford, MA)  using a protein A cartridge (POROS® A20 column,
.1 mmD  × 30 mmH,  104 L, Invitrogen, Grand Island, NY). Samplescultivation. (C) Western blot of the 3 PYC2 clones exhibiting overexpression of PYC2
after 2 month in culture (D) Western blot analysis of PYC2 expression in the cytosolic
fraction. Lanes 1–3: PYC2 positive clones. Lane 4: parental cell line (untransfected).
were ﬁltered by centrifugation at 8000–11,000 × g for 3 min using
NANOSEP MF  GHP 0.45 m centrifugal devices (PALL Life Sciences)
prior to being injected on the column at a ﬂow rate of 2 mL/min
(PBS) and elution was  performed using 0.15 M NaCl, pH 2.0. UV
detection was done at 280 nm.
3. Results
3.1. Generation of CHO clones overexpressing PYC2
The pTT18 vector encoding the yeast pyruvate carboxylase 2
gene was  transfected in CHO cells stably expressing a chimeric
human-llama heavy chain monoclonal antibody (EG2). 129 indi-
vidual clones were assessed for their level of PYC2 expression
by western blot (Fig. 1A). For the parental cell line (Lane 1), the
observed signal corresponds to the presence of the endogenous
pyruvate carboxylase (PC) naturally expressed in the mitochon-
dria of cells and which bears the same apparent molecular weight.
PYC2-expressing clones (e.g., lanes 2, 4, 7 and 24 in Fig. 1A) all dis-
played a stronger signal reﬂecting the combined expression of PC
and PYC2. Clones transfected with the pTT18 vector but showing a
signal similar to the parental cells (e.g., lanes 3, 5, 6, 8–23 and 25 in
Fig. 1A) were considered as negative. Finally, 11 clones that exhib-
ited signiﬁcant PYC2 expression were selected and used for further
analysis (Fig. 1B). Given that PYC2 is expected to be expressed
in the cytosol (in contrast to endogenous PC that is localized in
the mitochondria), a subcellular fractionation was performed on
three PYC2-positive clones (clones 1, 7 and 11 from Fig. 1C) that
were selected on the basis of their stable PYC2 expression for over
2 months in culture. As shown in Fig. 1D, western blot analysis
C. Toussaint et al. / Journal of Biotechnology 217 (2016) 122–131 125
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Fig. 3. (A) Final lactate and (B) ammonia concentrations for PYC2 and parental
cell lines cultivated in 4 different media in shake-ﬂask cultures. Error bars depict
standard deviations of the measurements. ND: medium not tested for clones 1 and
2.
Fig. 4. Evolution of pH for the parental cell line and 3 PYC2 positive clones cultivatedig. 2. (A) Lactate and (B) viable cell concentration proﬁles for PYC2 clones com-
ared to PYC2 negative clones and the parental cell line cultivated in shake-ﬂask
ultures.
evealed a signal corresponding to PYC2 that was indeed speciﬁc to
he transfected clones and conﬁrmed its proper expression in the
ytosol. As expected, GAPDH expression was observed in all the
ytosolic fractions.
.2. Phenotypic evaluation of PYC2 clones
To rapidly assess the impact of PYC2 expression on cell growth
nd metabolism, 11 PYC2-positive clones were cultivated in shake
asks operated in fed-batch mode, whereby glucose was  added on
 daily basis to maintain a target concentration of 20 mM.  Main-
aining glucose in excess was used to create conditions favoring an
verﬂow metabolism (i.e., lactate production) and to avoid limita-
ions that could alter lactate metabolism as reported in previous
tudies (Altamirano et al., 2006; Martínez et al., 2013). To rule out
otential effects attributable to clonal variation, the kinetics of cell
rowth and lactate production of the 11 PYC2-positive clones were
valuated and compared to that of the parental cell line and to 4
YC2-negative clones that were randomly chosen to serve as neg-
tive controls. As shown in Fig. 2A and in striking contrast with
he negative clones and the parental cells, all the PYC2-expressing
lones exhibited the same altered metabolism characterized by a
igniﬁcant shift towards lactate consumption around day 6. Note-
orthy, cell growth was not negatively impacted and most of the
ositive clones even reached slightly higher maximum viable cell
oncentrations (Fig. 2B).
Several studies have previously shown that the culture medium
omposition can strongly inﬂuence the metabolism of a given
ell line, including its pattern of lactate production/consumption
Altamirano et al., 2006; Luo et al., 2012; Ma  et al., 2009; Yuk
t al., 2014; Zagari et al., 2013a). In order to conﬁrm the consis-
ency of the metabolic shift displayed by the PYC2 clones, cellsin  6 well plates equipped with pH sensors (HydroDish®). The 3 pH peaks indicated
by arrows correspond to sampling of the cultures.
were cultivated in 5 commonly used commercial media. As shown
in Fig. 3A, the ﬁnal lactate concentrations varied depending on the
culture medium, but were always consistently lower in the case
of the PYC2-expressing clones compared to the parental cells. It
should be emphasized that the differences observed were not the
result of signiﬁcant changes in cell densities, as the calculated cell
speciﬁc lactate production rates were also consistently lower for
PYC2 clones compared to the parental cell line (data not shown).
Of salient interest, signiﬁcant reductions in ﬁnal ammonia concen-
trations (up to 50%) were also observed for PYC2 clones in three of
the ﬁve commercial media formulation tested (Fig. 3B).
Lactate accumulation and the consequent medium acidiﬁcation
in uncontrolled ﬂask cultures can be detrimental to the cells and/or
the product quality. We  therefore investigated the impact of PYC2
expression on the evolution of pH. To that end, cells were cultivated
in batch mode in a 6-well plates and pH was  monitored using a
sensor dish reader (SensorDish®). The recorded pH signals are pre-
sented in Fig. 4 and clearly demonstrate that the acidiﬁcation of the
126 C. Toussaint et al. / Journal of Biotechnology 217 (2016) 122–131
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(ig. 5. (A) Cell density, (B) cell viability, (C) glucose, (D) lactate, (E) glutamine and
nd  PYC2-expressing cells in shake-ﬂask cultures. Error bars depict standard deviat
edium is signiﬁcantly reduced in cultures performed with PYC2
lones.
.3. Batch and fed batch cultivations in shake ﬂasks
In order to assess the potential of PYC2 clones for fed-batch
pplications, cells were cultivated in shake ﬂasks under batch and
ed-batch modes using the BalanCD medium, which yielded the
ighest cell density in shake ﬂask batch cultures. Clone #11 (Fig. 1)
as used in all the subsequent experiments in shake ﬂask and
ioreactor cultures. The resulting cell density proﬁles are shown
n Fig. 5A for both the parental and PYC2-expressing cells. When
ultivated in batch mode, the growth curves differed markedly
etween both cell lines. The PYC2 cell line reached a maximum
ell concentration of about 1 × 107 cells/mL, a nearly two-fold
ncrease compared with the parental cells. The maximum cell spe-
iﬁc growth rates were also fairly different for the two  cell lines
0.033 and 0.023 h−1 for the PYC2 and the parental clones, respec-monia concentration proﬁles during batch and fed-batch cultivations of parental
f the measurements.
tively) and the exponential phase of the PYC2 clone was  extended
by more than 24 h. Upon reaching their maximum cell density on
day 6, the PYC2 cells exhibited a sharp decrease in viable cell con-
centration thereafter (Fig. 5B). This sudden drop in cell viability was
most likely due to a key nutrient depletion given the high cell den-
sity reached in these batch cultures. When grown in fed-batch, the
PYC2 cells had a similar cell speciﬁc growth rate (0.032 h−1), but
the feeding strategy allowed to maintain high cell densities over
a prolonged period of time, as the cell viability decreased below
85% only after day 7. In contrast, the same feeding regime had only
marginal impact on the growth and viability of the parental cells
(Fig. 5A & B) compared with the batch mode.
Batch cultures were characterized by a nearly total depletion of
glucose by day 8 for both PYC2 and parental cells (Fig. 5C), while
the fed-batch strategy allowed to maintain glucose around the tar-
get concentration of 35 mM.  Noteworthy, despite those elevated
glucose concentrations, the PYC2 clone exhibited the same altered
lactate metabolism witnessed in batch (Fig. 5D). A comparison of
C. Toussaint et al. / Journal of Biotechnology 217 (2016) 122–131 127
Table  1
Cell speciﬁc consumption/production rates in shake ﬂask cultures.
Batch Fed-batch
Exponential phase PYC2 Parental PYC2 Parental
qglucose (pmol/cell.d) 1.00 ± 0.17 1.24 ± 0.21 1.18 ± 0.19 1.65 ± 0.30
qglutamine (pmol/cell.d) 0.35 ± 0.06 0.37 ± 0.07 0.47 ± 0.08 0.53 ± 0.09
qlactate (pmol/cell.d) 0.46 ± 0.06 0.98 ± 0.18 0.54 ± 0.09 1.18 ± 0.21
qammonia (pmol/cell.d) 0.57 ± 0.10 0.86 ± 0.18 0.93 ± 0.20 1.31 ± 0.28
Lactate/glucose ratio 0.46 0.79 0.46 0.72
Ammonia/glutamine ratio 1.63 2.32 1.98 2.47
Stationary phase
q glucose (pmol/cell.d) 0.69 ± 0.10 1.19 ± 0.21 1.42 ± 0.24 1.73 ± 0.29
q glutamine (pmol/cell.d) – – 0.27 ± 0.05 0.31 ± 0.05
q lactate (pmol/cell.d) −0.36 ± 0.06 −0.05 ± 0.01 −0.15 ± 0.03 −0.03 ± 0.01
– 
−0
– 
t
d
T
t
c
c
T
l
F
cq ammonia (pmol/cell.d) – 
Lactate/glucose ratio −0.52 
Ammonia/glutamine ratio – 
he main cell speciﬁc consumption and production rates evaluated
uring the exponential and the stationary phases is presented in
able 1. In batch and fed-batch cultures, only slight reduction in
he glucose speciﬁc consumption rates were observed for PYC2
ells, but marked differences were noted for lactate as the spe-
iﬁc production was reduced by 50% during the exponential phase.
he differences were even greater during the stationary phase, as
actate was signiﬁcantly consumed by PYC2 cells, unlike in the
ig. 6. (A) Cell viability, (B) cell density, (C) glucose, (D) lactate (E) glutamine and (F) amm
lones in bioreactor cultures. Error bars depict standard deviations of the measurements.0.41 ± 0.09 0.36 ± 0.08
.04 −0.11 −0.02
1.52 1.16
parental cell line (Table 1). As evident from the calculated lac-
tate/glucose ratios, the PYC2 clone exhibited a much more efﬁcient
glucose utilization.
In batch cultures, glutamine depletion occurred rapidly (by
day 4), but the average cell speciﬁc glutamine consumption rates
were not signiﬁcantly different for the two cell lines (Fig. 5E
& Table 1). The supplementation of glutamine in fed-batch cul-
tures led to an increased consumption rate and greater ammonia
onia concentration proﬁles fed-batch cultivations of parental and PYC2 expressing
128 C. Toussaint et al. / Journal of Biotechnology 217 (2016) 122–131
Table 2
Cell speciﬁc consumption/production rates in bioreactor cultures.
Exponential phase Stationary phase
PYC2 Parental PYC2 Parental
qglucose (pmol/cell.d) 2.46 ± 0.42 2.49 ± 0.44 1.57 ± 0.27 2.06 ± 0.33
qglutamine (pmol/cell.d) 0.75 ± 0.12 1.18 ± 0.20 0.44 ± 0.08 0.56 ± 0.09
qlactate (pmol/cell.d) 0.43 ± 0.07 2.34 ± 0.41 −0.17 ± 0.03 0.24 ± 0.04
qammonia (pmol/cell.d) 0.31 ± 0.05 1
Lactate/glucose ratio 0.17 0
Ammonia/glutamine ratio 0.41 0
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rig. 7. Comparison of maximum antibody titers between parental and PYC2-
xpressing cells cultivated in shake ﬂasks and bioreactors. Error bars depict standard
eviations of the measurements.
ccumulation, particularly for the PYC2 clone due to the greater
ell density and the prolonged culture. While the speciﬁc produc-
ions were quite similar during the exponential phase, both cell
ines showed a decreased production of ammonia per cell during
he stationary phase (Table 1). Whether the cultures were per-
ormed in batch or fed-batch modes, the ﬁnal product titer in
ultures with PYC2-expressing cells was 35% greater compared to
he parental cell line (Fig. 7). This augmentation can be attributed to
oth the increased cell density and the prolonged culture longevity
ssociated with PYC2 expression. The cell speciﬁc productivity
f PYC2-expressing cells was comparable in batch and fed-batch
odes (1.91 ± 0.40 and 2.02 ± 0.44 pg/cell day, respectively), while
hat of the parental clone increased from 1.69 ± 0.35 pg/cell day
n batch to 2.69 ± 0.54 pg/cell day in fed-batch. Compared to the
arental cell line, the slightly lower cell speciﬁc productivity of the
YC2 clone is largely compensated by the increased cell growth.
.4. Fed-batch cultivation in bioreactor
The sharp and sudden viability decrease witnessed in shake
asks suggested that these uninstrumented culture conditions
ould not support the high cell densities reached by PYC2 cells
around 1 × 107 cells/mL). Cells were thus cultivated under fed-
atch mode using fully controlled bioreactors so as to provide better
egulated conditions in terms of pH and oxygen. The feeding strat-
gy consisted in the daily addition of a concentrated solution (CHO
D EfﬁcientFeed B) supplemented with 40 mM of glutamine. The
esulting cell density proﬁles are shown in Fig. 6A. The PYC2 cell line
eached a maximum cell concentration of about 1.3 × 107 cells/mL, more than 2-fold increase compared with the parental cells. The
aximum cell speciﬁc growth rates were fairly similar for the two
ell lines (0.023 and 0.024 h−1 for the PYC2 and the parental clones,
espectively), but the exponential growth phase was  extended by 3.11 ± 0.18 0.19 ± 0.03 0.24 ± 0.02
.79 -0.11 0.11
.94 0.43 0.82
days in the case of the PYC2 clone. Upon reaching their maximum in
concentration between days 9 and 12 (13 × 106 cells/mL), there was
a sharp decrease in viable cell density, similar to the trend observed
in small-scale cultures (Fig. 6B). Since the dissolved oxygen set-
point was successfully maintained at around 50% throughout the
culture, this was  likely due to some other nutrient limitation.
As was  observed in shake ﬂask cultures, the expression of the
PYC2 gene led to a signiﬁcant alteration of the cell metabolism, with
lactate being consumed after 7 days of cultivation despite elevated
glucose concentration (Fig. 6C & D). The greater nutrient utiliza-
tion efﬁciency of the PYC2 cell line was even observed during the
exponential phase, as the cell speciﬁc lactate production rate was
reduced by 80% for a comparable glucose uptake rate (Table 2). PYC2
expression did not signiﬁcantly impact the glutamine metabolism,
and, as a result, the cultures achieved similar ﬁnal levels of ammo-
nia (Fig. 6E & F), although the speciﬁc ammonia production rate of
the PYC2 clone was  lower (Table 2).
Consistent with small-scale fed-batch results, the average cell
speciﬁc antibody production rates was  slightly lower for the PYC2
clone (2.21 ± 0.45 and 2.86 ± 0.58 pg/cell day for PYC2 and parental
cells), but the ﬁnal product titer was  augmented by 28% due to the
higher cell density achieved (Fig. 7). Of interest, the maximum vol-
umetric titer was  reached 4 days earlier in cultures with the PYC2
cells. While the fed-batch strategy brought only a slight antibody
volumetric productivity improvement in shake ﬂasks, cultures in
bioreactor improved by around 30–40% the volumetric production
of PYC2 and parental cell lines, respectively.
4. Discussion
The aim of this work was to generate a PYC2-expressing CHO
cell line with an improved metabolic efﬁciency and demonstrate its
potential for the development of a fed-batch process for antibody
production. In any metabolic engineering strategy, clonal variations
should be considered when trying to assess the real impact of gene
overexpression. Clone-based studies often fail to establish a rela-
tionship between transgene expression and the desired trait. In the
speciﬁc case of lactate reduction strategies, a variety of other factors
may  cause differences in metabolic phenotypes, such as changes in
the medium composition (Kishishita et al., 2015; Luo et al., 2012;
Zagari et al., 2013a). In our study, we  have initially compared the
kinetics of growth and metabolite formation of 11 PYC2-positive,
4 PYC2-negative and the parental clones. The fact that all 11 PYC2-
positive clones exhibited comparable phenotypes when tested in
different media formulation provided strong evidence that the dif-
ferences observed were due to PYC2 expression and not to clonal
variations.
The PYC2 expressing CHO cells that were generated displayed
a much more efﬁcient metabolism characterized by a lower
lactate/glucose ratio, especially in fed-batch cultures using an
enriched nutrient solution. More importantly, the slightly lower
cell speciﬁc antibody production of the PYC2 clone is largely com-
pensated by the increase in maximum cell density, translating
into a net gain in volumetric productivity. PYC2 expressing cells
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aintained their distinctive phenotype, even when exposed to
igh glucose levels during fed-batch cultures. In addition, the cell
peciﬁc productivity is not signiﬁcantly altered by the metabolic
odiﬁcation, as was previously observed when the same gene
as overexpressed in HEK293 cells producing interferon in batch
Henry and Durocher, 2011) or fed-batch (Vallée et al., 2013) cul-
ures. In contrast with our results, an apparent two-fold increase
n speciﬁc productivity was observed in PYC2 transfected BHK-21
ells producing recombinant EPO, although these cells were culti-
ated in perfusion mode under limiting glucose conditions (Irani
t al., 2002). However, no positive impacts were observed in terms
f maximum cell density and cell speciﬁc growth rate. Similarly,
 two-fold increase of speciﬁc hGM-CSF productivity was  noted
or CHO cells expressing PYC2 cultivated in batch and following a
emperature switch (Fogolín et al., 2004). The cell speciﬁc growth
ate and maximum cell density were reduced, but culture longevity
as extended leading to a rise in ﬁnal product titer. In an earlier
tudy, HEK293 expressing PYC2 showed no signiﬁcant increase in
EAP titer in spite of increase cell longevity and reduced waste
roduction (Elias et al., 2003). Similarly, a decrease in the speciﬁc
ntibody productivity was found for CHO cells expressing PYC2,
ven though the cell growth rate and glucose/lactate ratio were
mproved (Wilkens and Gerdtzen, 2015). Taken together, these
esults indicate that the effects of PYC2 expression are dependent
n the cell type and the culture conditions. In the present study, the
reatest impact of PYC2 expression in CHO cells was  on the max-
mum cell density attained during the cultures. Results from our
hake ﬂask and bioreactor cultures in fed-batch mode showed that
he increase in cumulative viable cell concentration, combined with
he maintenance of antibody speciﬁc productivity, resulted into a
et increase in the ﬁnal volumetric titer.
In the transition from small-scale to bioreactor, the metabolism
nd growth of the PYC2 clone remained mostly similar, but the
roduct titer increased substantially. This titer improvement can
ikely be attributed, at least in part, to tightly regulated conditions
n the bioreactor. In the case of PYC2 cells, regardless of the cul-
ure mode (batch or fed-batch) or culture device (shake ﬂask or
ioreactor), the lactate shift seemed to occur systematically 24 h
efore reaching the maximal cell density, as the cells entered the
eceleration phase. For the parental CHO cell line, the net accumu-
ation of lactate ceased when cell growth stopped. In either of the
wo cell lines, these results suggest a link between a certain lactate
evel, growth rate reduction and lactate production shutdown. In
he case of cells expressing PYC2, the enzyme could have an additive
ffect leading to a net lactate consumption due to the competition
or pyruvate between this enzyme and lactate dehydrogenase (Irani
t al., 1999). Lactate consumption has been reported to occur under
ow glucose concentrations (Altamirano et al., 2004; Cruz et al.,
000; Ozturk et al., 1992) or under non-limiting levels (Luo et al.,
012; Ma  et al., 2009; Mulukutla et al., 2012; Ozturk et al., 1997;
ascoe et al., 2007). The co-consumption of lactate and glucose was
dentiﬁed as a highly desirable trait for industrial cell lines, since it
s typically associated with increased culture longevity and greater
roduct yields (Le et al., 2012). This phenomenon and its under-
ying physiological mechanisms are still not fully understood and,
onsequently, not yet well-controlled. Recently, some studies have
uggested that the copper level in the culture medium could be a
rigger of lactate consumption (Luo et al., 2012; Yuk et al., 2014),
ut other factors have also been associated to this metabolic shift,
ncluding an increase in oxygen consumption, a reduction of gly-
olysis and glutaminolysis, as well as cell growth slowdown (Luo
t al., 2012; Ma  et al., 2009; Mulukutla et al., 2012; Pascoe et al.,
007).
Studies on BHK-21 expressing PYC2 have reported increases in
xygen uptake and intracellular ATP pool, pointing to an enhanced
CA activity resulting from this genetic modiﬁcation (Irani et al.,hnology 217 (2016) 122–131 129
1999). More recently, 13C metabolic ﬂux analysis conducted on
HEK293-PYC2 expressing cells conﬁrmed an increase in the pyru-
vate ﬂux to oxaloacetate (Henry and Durocher, 2011), although
this intermediate metabolite can subsequently have multiple fates.
First, in the cytosol, the latter can be accumulated or could be con-
verted into malate through cytosolic malate dehydrogenase (MDH)
with the concomitant release of NAD+. Then the malate can be
recycled into pyruvate via cytosolic malic enzyme or enter the mito-
chondria via the malate/aspartate shuttle to be completely oxidized
in the TCA. A previous study on CHO cells expressing mitochondrial
MDH II reported enhanced glycolysis, reduced lactate secretion and
elevated intracellular ATP/NADH levels along with antibody titer
improvement (Chong et al., 2010). These ﬁndings suggest a criti-
cal role of the redox balance in the regulation of the glycolytic ﬂux
and the proportion of pyruvate entering the TCA. The capacity of
the LDH reaction to regenerate NAD+ allows to maintain high gly-
colytic rates, decreasing the availability of cytosolic pyruvate as
a substrate for the TCA cycle. The malate-aspartate shuttle plays
a pivotal role in maintaining the redox balance by allowing the
regeneration of NAD+ in the cytosol. In CHO cells, overexpression
of aralar1, an aspartate/glutamate carrier and critical component of
the malate-aspartate shuttle, was shown to promote a metabolic
switch to lactate consumption without any reduction of the gly-
colytic rate (Zagari et al., 2013b). For PYC2 overexpression, it can
be speculated that the reduction in the LDH ﬂux is likely compen-
sated by an increase in the malate dehydrogenase ﬂux to maintain
the redox balance.
The distinctive phenotype of PYC2-expressing CHO cells can
provide additional beneﬁts in the context of the development of
a cell culture manufacturing process. First, it is well known that
glycosylation pattern of glycoproteins can be negatively altered
by elevated waste product accumulation (Andersen and Goochee,
1995; Gawlitzek et al., 2000; Yang and Butler, 2002). Since signif-
icant lactate/ammonia accumulation is likely to occur in standard
high cell density fed-batch cultures, the lower waste metabolite for-
mation obtained in PYC2 cells could be expected to enhance ﬁnal
product quality and stability in the culture medium, but further
work is required to assess the impact of PYC2 overexpression on
product quality attributes. Furthermore, this phenotypic change
eliminates the need to control glutamine/glucose at low levels,
strategies which make process operation more complex and also
have adverse effects on the glycosylation proﬁle of the protein
of interest (Liu et al., 2014). Second, it is generally recognized
that small-scale studies performed in shake ﬂasks during process
development may  not translate well to bioreactor during scale-up,
particularly due to lactate accumulation. Given that the pH changes
are damped with PYC2-expressing cells, this represents another
signiﬁcant advantage to streamline the optimization of culture con-
ditions.
5. Conclusion
We have demonstrated that PYC2 expression in CHO cells can
efﬁciently alter their metabolism and induce a desired shift towards
lactate consumption that was shown to occur consistently in all
culture modes and commercial media tested. Given the marked
reduction in waste metabolite formation, the results presented here
demonstrate that PYC2 cells are well suitable for fed-batch process
employing concentrated feed solutions. Indeed, a simple feeding
strategy based on glucose consumption was  able to substantially
increase culture growth and longevity and lead to a signiﬁcant
improvement of the volumetric titer. Since the cell speciﬁc pro-
ductivity of PYC2 clones was marginally reduced compared to the
parental cells, this enhancement was  attributable to the signiﬁ-
cant increase in maximum cell density. Further improvement could
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otentially be achieved by screening key culture supplements or
rocess conditions leading to increased culture longevity and/or
timulating the cell speciﬁc productivity (e.g. mild hypothermia
onditions).
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